.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Combination Cancer Therapy
. Ed(S): Schwartz, Gary E., Ph.D.
€ 199.82
FREE Delivery in Ireland
Description for Combination Cancer Therapy
Hardback. Reviews those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and details their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. Editor(s): Schwartz, Gary E., Ph.D. Series: Cancer Drug Discovery and Development. Num Pages: 284 pages, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 17. Weight in Grams: 1310.
Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future ... Read more
Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future ... Read more
Product Details
Format
Hardback
Publication date
2004
Publisher
Humana Press Inc. United States
Number of pages
284
Condition
New
Series
Cancer Drug Discovery and Development
Number of Pages
284
Place of Publication
Totowa, NJ, United States
ISBN
9781588292001
SKU
V9781588292001
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Combination Cancer Therapy
"It offers everyone in the field of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects of cancer patients." - Neoplasma